Philip C Prorok

6PUBLICATIONS
36CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingCancer diagnosisRecommender systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 04, 2025
Framework to Select Multi-Cancer Detection Assays in the National Cancer Institute's Vanguard Study.

Elyse LeeVan, Amanda L Skarlupka, Christos Patriotis

|Apr 17, 2025
Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program.

Brandy M Heckman-Stoddard, Jill P Crandall, Sharon L Edelstein

|Oct 09, 2024
Design of randomized controlled trials to estimate cancer-mortality reductions from multicancer detection screening.

Ping Hu, Philip C Prorok, Hormuzd A Katki

|Mar 22, 2024
Cancer screening with multicancer detection tests: A translational science review.

Wendy S Rubinstein, Christos Patriotis, Anthony Dickherber

|Dec 02, 2022
Study design considerations for trials to evaluate multicancer early detection assays for clinical utility.

Lori M Minasian, Paul Pinsky, Hormuzd A Katki

|May 26, 2017
Data sharing in clinical trials: An experience with two large cancer screening trials.

Claire S Zhu, Paul F Pinsky, James E Moler

Pageof 1